GIT2

ARF GTPase-activating protein GIT2

759 amino acids

GTPase-activating protein for the ADP ribosylation factor family.

84.543 kDa

MSKRLRSSEVCADCSGPDPSWASVNRGTFLCDECCSVHRSLGRHISQVRHLKHTPWPPTLLQMVETLYNNGANSIWEHSLLDPASIMSGRRKANPQDKVHPNKAEFIRAKYQMLAFVHRLPCRDDDSVTAKDLSKQLHSSVRTGNLETCLRLLSLGAQANFFHPEKGNTPLHVASKAGQILQAELLAVYGADPGTQDSSGKTPVDYARQGGHHELAERLVEIQYELTDRLAFYLCGRKPDHKNGQHFIIPQMADSSLDLSELAKAAKKKLQSLSNHLFEELAMDVYDEVDRRETDAVWLATQNHSALVTETTVVPFLPVNPEYSSTRNQGRQKLARFNAHEFATLVIDILSDAKRRQQGSSLSGSKDNVELILKTINNQHSVESQDNDQPDYDSVASDEDTDLETTASKTNRQKSLDSDLSDGPVTVQEFMEVKNALVASEAKIQQLMKVNNNLSDELRIMQKKLQTLQSENSNLRKQATTNVYQVQTGSEYTDTSNHSSLKRRPSARGSRPMSMYETGSGQKPYLPMGEASRPEESRMRLQPFPAHIGRSALVTSSSSLPSFPSTLSWSRDESARRASRLEKQNSTPESDYDNTPNDMEPDGMGSSRKGRQRSMVWPGDGLVPDTAEPHVAPSPTLPSTEDVIRKTEQITKNIQELLRAAQENKHDSYIPCSERIHVAVTEMAALFPKKPKSDMVRTSLRLLTSSAYRLQSECKKTLPGDPGSPTDVQLVTQQVIQCAYDIAKAAKQLVTITTKENNN

Git2

ARF GTPase-activating protein GIT2

708 amino acids

GTPase-activating protein for the ADP ribosylation factor family.

78.766 kDa

MSKRLRSSDVCADCNGPDPSWASVNRGTFICDECCSVHRSLGRHISQVRHLKHTAWPPTLLQMVETLYNNGANSIWEHSLLDPASIMSGRRKANPQDKVHPNKAEFIRAKYQMLAFVHRLPCREDDSVTAKDLSKQLHSSVRTGNLETCLRLLSLGAQANFFHPEKGSTPLHVASKAGQILQAELLAVYGADPGTQDSSGKTPVDYARQGGHHELAERLIEIQYELTDRLAFYLCGRKPDHKSGQHFLIPQRADSLDLSELAKAAKKKLQSLSNHLFEELAMDVYDEVDRRETDAVWLATQNHSTLVTETTVVPFLPVNPEYSSTRNQGRQKLARFNAHEFATLVIDILSDAKRRQQGSPLSRSKDNVELILRTVSTQHSTESQDNDQPDYDSVASDEDTDVETRASKANRQKLQTLQSENSSLRRQATASACQVQTGSDHKDTASHSSLKRRPSARGSRPMSMYETGSGQKPYLPMGEASHPEESRTRLQPFPTHIGRSALVTSSSSLPSFPSTLSWSRDESARRASRLEKQNSTPESDYDNTACDPEPDDTGSTRKGRQRSMLWQGDGLLPDTAEPHSVPSPTLPSTEDVIRKTEQITKNIQELLRAAQENKHDSYIPCSERIHVAVTEMAALFPKKPKSDTVRTSLRLLTSSAYRLQSECRKALPGDSSLPTDVQLVTQQVIQCAYDIAKAAKQLVTITTKENSS

GIT2

Glycerophosphodiester transporter GIT2

534 amino acids

Probable glycerophosphodiester transporter (PubMed:24114876). Does not possess detectable glycerophosphoinositol (GroPIns) transport activity (PubMed:24114876). Might be involved in the uptake of glycerophosphocholine (GroPCho) (PubMed:24114876). The expanded ability to utilize GroPIns and GroPCho results from the organism's pathogenic nature and its need to occupy a variety of environments within its host organism (PubMed:24114876). This possibility is buttressed by the fact that GroPIns and GroPCho are present and abundant in human fluids (PubMed:24114876).

Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family.

59.304 kDa

MASRDLPHSLNDLAFGWIKHLKEEIIINKNSQQLVDEDFQPDEDVTKETKVKLNNLWPAFASGAGLFADGYVNNSIGIVMACLKILYGDEFTKSNAISNIGSIGFVGTVVGQLSFGYISDRVARKGGMMTANIMLIAFTLLCAVGSWGTTIQGFFACLTVWRFCLGVAIGAEYPTSSVIASEFANQLPAGKRNRYFIWFTGFMIDFGFVVSAFVPFVLLWIFTEKHLRALWRVSIGLGAILPTALFFIRLKMKDSTSFEKLHMKNVRYRDYPWWLIVKFYWFRLTIVSMIWFIYNFSVYSFGTFNAIILGQIIPDAPLWQQWGWSVVFNLFYIPGSFLGAFSADYLGPRLTLAIGVGLQGIIGFIMSACLNGLRKQVAAFTVVFGIFATLGEFGPGGNIGLLASKTSATPIRGQYYGIAAAMGKIGAFVGTWIFPAIQRRYASKTNPDLELQVPFYLSSGLCIFSALLTFFLCPHVGQDAINREDKEFVEYLRKNGFDVSKLGEDSSSVDVDVVKDTDSAEKISETIEVGQKLA